Imperial College London
Portrait Picture

Dr Paul Turner

Faculty of Medicine, National Heart & Lung Institute

Reader in Paediatric Allergy & Clinical Immunology
 
 
 
//

Contact

 

+44 (0)20 3312 7754p.turner

 
 
//

Location

 

Children's Clinical Research FacilityCambridge WingSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Mack:2022:10.1111/cea.14225,
author = {Mack, DP and Greenhawt, M and Turner, P and Wasserman, RL and Hanna, MA and Shaker, M and Hughes, SW and Rodriguez, del Rio P},
doi = {10.1111/cea.14225},
journal = {Clinical and Experimental Allergy},
pages = {1391--1402},
title = {Information needs of patients considering oral immunotherapy for food allergy},
url = {http://dx.doi.org/10.1111/cea.14225},
volume = {52},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - While the historic management of food allergy includes avoidance strategies and allergic reaction treatment, oral immunotherapy (OIT) approaches have become more commonly integrated into therapeutic approaches.   International guidelines, phase 3 trials and real-world experience have supported the implementation of this procedure.  However, OIT is an elective, rarely curative procedure with inherent risks that necessitates an increased degree of health literacy for the patients and families.   Families assume the responsibility of amateur health care providers to ensure the daily safe administration of the allergenic food.  As such, it is incumbent upon physicians to ensure that families are prepared for this role.  A thorough educational and shared decision-making approach is necessary during the counseling and consent process to adequately inform the families.  Educated discussion about the efficacy and patient-centred effectiveness, therapeutic alternatives, and family goals is required to align physician and patient expectations.   A frank discussion about the struggles, practical challenges, risks and contraindications can help to develop an understanding of the risk mitigation strategies employed to maintain safety.   Physicians should develop a proactive approach to educate families about this, at times, burdensome procedure.  This educational approach should encourage ongoing support starting prior to consent through the maintenance visits.  By preparing families for their unique management role, physicians can help ensure the safe and successful integration of OIT into the therapeutic offering for the management of food allergies.
AU  - Mack,DP
AU  - Greenhawt,M
AU  - Turner,P
AU  - Wasserman,RL
AU  - Hanna,MA
AU  - Shaker,M
AU  - Hughes,SW
AU  - Rodriguez,del Rio P
DO  - 10.1111/cea.14225
EP  - 1402
PY  - 2022///
SN  - 0954-7894
SP  - 1391
TI  - Information needs of patients considering oral immunotherapy for food allergy
T2  - Clinical and Experimental Allergy
UR  - http://dx.doi.org/10.1111/cea.14225
UR  - https://onlinelibrary.wiley.com/doi/10.1111/cea.14225
UR  - http://hdl.handle.net/10044/1/99603
VL  - 52
ER  -
Download